Welcome to our dedicated page for Regional Health SEC filings (Ticker: RHE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing Regional Health Properties’ disclosures can feel like navigating a skilled-nursing facility’s floor plan in the dark—hundreds of pages, tenant health metrics buried in footnotes, and Form 8-K updates that land without warning. If you have ever asked, “How do I track Regional Health Properties insider trading Form 4 transactions?” or “Where is the latest Regional Health Properties quarterly earnings report 10-Q filing?”, this page is built for you.
Stock Titan’s AI pinpoints what matters in every submission. Need rent coverage ratios from the annual report? Our engine highlights them inside the Regional Health Properties annual report 10-K simplified summary. Curious about executive moves? Get Regional Health Properties Form 4 insider transactions in real-time, complete with easy-to-read charts. Material event just posted? Our alert breaks down the Regional Health Properties 8-K material events explained section before the market opens.
Here’s what you’ll uncover:
- Income trends and occupancy shifts inside each Regional Health Properties earnings report filing analysis (10-Q)
- Board decisions on operator renewals in the proxy statement executive compensation filings
- Facility acquisitions, divestitures, and reimbursement updates distilled from 8-Ks
- Understanding Regional Health Properties SEC documents with AI—plain-language explanations replace dense legalese
All filings stream directly from EDGAR the moment they post, then flow through our AI for concise summaries, keyword search, and side-by-side comparisons. Stop sifting through PDFs; start making decisions faster with filings that are finally clear.
Regional Health Properties has received a Notice of Effectiveness from the SEC for their Form S-4 registration statement, effective as of June 25, 2025, at 4:00 P.M. The Form S-4 (File Number: 333-286975) indicates a significant corporate action, typically involving:
- A potential merger, acquisition, or business combination
- Exchange offer of securities
- Corporate restructuring
This effectiveness notice means the SEC has completed its review and the registration statement is now active, allowing the company to proceed with their planned transaction. Investors should review the full S-4 filing for detailed information about the proposed corporate action and its potential impact on their investment.
Avidity Biosciences, Inc. (RNA) Form 4 filing: Chief Program Officer Kathleen P. Gallagher reported a single open-market sale of company common stock executed on 06/17/2025. The sale, carried out under a previously established Rule 10b5-1 trading plan (adopted 06/12/2024), involved 911 shares at a price of $30.24 per share.
Following the transaction, Gallagher’s direct holding stands at 50,392 shares. The filing was signed on 06/18/2025 and indicates that the Form 4 was filed by one reporting person only. No derivative transactions or additional equity awards were disclosed.
The relatively small share quantity and continued sizeable ownership suggest the transaction is routine in nature rather than signaling a material change in insider sentiment.
Brent Morrison, CEO, President and Director of Regional Health Properties (NYSE: RHE), reported significant insider transactions on June 20, 2025:
- Exercised two stock options: - 24,000 shares at $3.32 per share - 24,000 shares at $2.03 per share
- Received a grant of 65,000 restricted shares as 2023 bonus compensation, vesting in equal installments on June 20, 2026 and 2027
- Following these transactions, Morrison now beneficially owns: - 198,047 shares directly - 2,272 shares indirectly through an IRA
The exercised options included a fully vested grant from January 2023 and another grant from January 2024 that completed vesting in January 2025. This significant increase in direct ownership demonstrates long-term commitment from the company's chief executive.
Regional Health Properties (RHE) and SunLink Health Systems have amended their Merger Agreement, extending the termination deadline from June 30, 2025, to August 11, 2025, 5:00 PM ET. This extension comes as both companies acknowledge that required shareholder approvals have not been obtained and are unlikely to be secured by the original deadline.
Key developments include:
- NYSE American filed Form 25 on June 11, 2025, to delist Regional's common stock and Series A Preferred Stock
- Both securities now trade on OTCQB under symbols "RHEP" and "RHEPA"
- Regional will file an S-4 Registration Statement including a joint proxy statement/prospectus for the proposed merger
The merger remains subject to several risks, including integration challenges, potential revenue synergy shortfalls, regulatory approvals, and shareholder approvals. The company cautions investors about forward-looking statements and urges review of the forthcoming joint proxy statement/prospectus for complete merger details.
FAQ
What is the current stock price of Regional Health (RHE)?
What is the market cap of Regional Health (RHE)?
What is the primary focus of Regional Health?
How does Regional Health generate revenue?
What distinguishes Regional Health in the healthcare real estate market?
What role do non-GAAP financial measures play for Regional Health?
How is Regional Health positioned in its competitive landscape?
What types of healthcare properties does Regional Health manage?
How does Regional Health maintain operational efficiency?
In what ways does Regional Health emphasize corporate governance?
